Examination Report |
1 | TM-16 | 21 Sep 2016 |
10 | TM-1 | |
10 | TM-R(RENEWAL OF TRADE MARK) | 15 Mar 2024 |
11 | TM-1 | |
2 | Reply to Exam Report (MIS-R) | 03 Nov 2017 |
3 | Reply to Exam Report (MIS-R) | 07 Nov 2017 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 10 Jan 2018 |
5 | Journal Copy | 17 May 2018 |
6 | Certificate | 11 Aug 2018 |
7 | Letter | 09 Aug 2019 |
8 | Letters related to POST REGISTRATION | 20 Aug 2019 |
9 | Letter | 17 Nov 2021 |
1 | Hearing Notice (Show Cause) | 5832449 | 2636130 | 06 Feb 2018 |
2 | Tribunal Accepted Notice for : 2711641 | 6047649 | 2631720 | 13 Mar 2018 |
3 | O3 NOTICE | 17040194 | 05 Jan 2024 | |
4 | O3 NOTICE | 17041081 | 6497609 | 05 Jan 2024 |
5 | RENEWAL INTIMATION LETTER | 17791154 | 21 Mar 2024 |
The application for Vizylac + was made on 04 April 2014.
The trademark applicant for Vizylac + is Torrent Pharmaceuticals Limited.
Vizylac + is applied in class(es) 5.
Application for Vizylac + is on Registered stage.
Application Id allotted to Vizylac + is 2711641.
Trademark agent or attorney for the application is Krishna & Saurastri Associates.
Vizylac + filed with the Intellectual property office as a DEVICE.